Hepatitis Virus-Related Hepatocellular Carcinoma

Hepatitis Virus-Related Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: SCG Cell Therapy Pte. Ltd.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05417932	A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma(TCR-T)	recruiting	Phase 1 / Phase 2	46	SCG Cell Therapy Pte. Ltd.INDUSTRY	3	Feb 18, 2025	clinicaltrials

Data updated 23 days agoSource updated Feb 18, 2025source: clinicaltrials